Medtronic plc (MDT) 当前追踪市盈率 (P/E) 为 24.4, 前瞻市盈率为 15.6. 追踪盈利收益率为 4.09%, 前瞻盈利收益率 6.43%. PEG 0.27 (Peter Lynch 低估标准 ≤1.0). 格雷厄姆数为 $55.74.
本页证实的标准:
SharesGrow 综合评分： 69/100 其中 3/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | 31.5 | 10.99 | 2.15 | 3.87 | 1.92% |
| 2017 | 28.7 | 1.75 | 2.30 | 3.89 | 2.06% |
| 2018 | 35.0 | -1.62 | 2.14 | 3.63 | 2.29% |
| 2019 | 25.8 | 0.51 | 2.39 | 3.91 | 2.25% |
| 2020 | 27.8 | 7.36 | 2.62 | 4.60 | 2.17% |
| 2021 | 48.8 | -1.96 | 3.42 | 5.85 | 1.77% |
| 2022 | 27.8 | 0.70 | 2.67 | 4.42 | 2.41% |
| 2023 | 32.2 | -1.31 | 2.35 | 3.87 | 2.99% |
| 2024 | 28.8 | -13.58 | 2.11 | 3.27 | 3.46% |
| 2025 | 23.2 | 0.75 | 2.25 | 3.23 | 3.32% |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2020 | $3.54 | $28.91B | $4.79B | 16.6% |
| 2021 | $2.66 | $30.12B | $3.61B | 12% |
| 2022 | $3.73 | $31.69B | $5.04B | 15.9% |
| 2022 | $3.73 | $31.69B | $5.04B | 15.9% |
| 2023 | $2.82 | $31.23B | $3.76B | 12% |
| 2023 | $2.82 | $31.23B | $3.76B | 12% |
| 2024 | $2.76 | $32.36B | $3.68B | 11.4% |
| 2024 | $2.76 | $32.36B | $3.68B | 11.4% |
| 2025 | $3.61 | $33.54B | $4.66B | 13.9% |
| 2025 | $3.61 | $33.54B | $4.66B | 13.9% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $5.65 | $5.57 – $5.71 | $36.16B | $36.03B – $36.24B | 8 |
| 2027 | $6.08 | $5.99 – $6.24 | $38.64B | $37.39B – $39.3B | 15 |
| 2028 | $6.53 | $5.84 – $7.15 | $40.64B | $40.48B – $40.8B | 9 |
| 2029 | $7.14 | $6.89 – $7.28 | $43.27B | $42.06B – $43.9B | 3 |
| 2030 | $7.77 | $7.49 – $7.92 | $45.56B | $44.28B – $46.23B | 3 |
